Having trouble viewing this e-mail? Click here

ModernMedicine/Physician's Focus
Optic Neuritis and Multiple Sclerosis

ModernMedicine has synthesized intelligence which details the predictive utility of MRIs for projecting the likelihood of MS in these patients, promising data on a novel therapy, and an exchange between two experts on the risks versus benefits of immune modulatory therapy in optic neuritis patients at greatest risk for MS.

Covered in the Physician�s Focus:

  • Brain MRI useful for predicting risk of MS in optic neuritis
  • New oral agent for optic neuritis suppressed neurological dysfunction in a preclinical model of MS
  • 15-year follow-up from Optic Neuritis Study Group shows positive long-term prognosis

Click here to access these resources…

You are subscribed to ModernMedicine. To unsubscribe, click here

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.